Major part in the Company manufacture is still covered by the tablets used in the treatment of the cardiovascular, gastroenterological, neurological and respiratory disorders.

Tablet manufacture takes up 86% of the total realized products. For 2007 are manufactured 480 million tablets. Tablet Workshop 2  is completely reconstructed and an additional tablet press and blister packaging machine are commissioned aiming to increase the production capacity responding to the higher market demand.

The working process is carried out through a flexible regime aiming to provide continuous manufacturing process, flexibility and precision in the fulfillment of the set deadlines for release of the finished products in the distribution network.

There is an agreed preliminary design between Unipharm and the Bulgarian Drug Agency for reconstruction and modernization of Tablet Workshop 1, conforming to the principles of Good Manufacturing Practice. The workshop will cover an area of 500 sq. m. as above EUR 1.5 million will be invested.

Tablet Workshop 1 will work with capacity of 250 million tablets per year and will increase twice the volume of tablet manufacture. The increased manufacturing capacity will enable Unipharm to respond to the increased consumption of medicinal products in the country, as well as establish the company as a reliable and flexible partner for contract manufacture development for the needs of the local and foreign markets.

At the end of 2006 Unipharm undertook the operating, methodological and functional management and quality control of Tablet Workshop 3, situated on the territory of Sopharma.

Covering a large part of the most significant pharmacotherapeutic categories defines the Company as a traditional and well established manufacturer intending to preserve the customers' trust and to ensure high quality medicinal products for human healthcare.